More than 90 percent of Illinois medical cannabis patients say they found pain relief with any strain of cannabis, based on results of a survey done by Revolution Cannabis Analytics.
Results from the first-of-its-kind study also show there is a statistically significant positive correlation between levels of cannabidiol, a compound in cannabis, and improvement in mood. In addition, 84.4 percent of responses indicate the patient would recommend the strain they used to treat their specific medical condition.
That’s no surprise to Christine Wildrick, chief operating officer for Quincy-based Herbal Remedies.
“It just further confirms what the patients in the medical cannabis industry have been saying for a very long time — that medical cannabis isn’t a joke. It truly is medicine, and it is very effective at treating pain,” Wildrick said. “This type of data is valuable. It further helps validate the program here in Illinois.”
The Medical Cannabis Patient Survey asked patients to rate their experience with each strain they buy, focusing on symptoms associated with pain, sleep, nausea and more. Herbal Remedies in Quincy was one of four Illinois dispensaries working with Revolution Cannabis Analytics on the study, which included 104 patients submitting 290 individual cannabis strain surveys from Dec. 7 through Jan. 8.
Medical cannabis has been available in Illinois since November for patients with qualifying medical conditions.
Herbal Remedies, open since Nov. 9, has about 100 patients with health conditions ranging from multiple sclerosis and cancer to fibromyalgia, spinal cord injuries and seizure disorders.
“We are seeing an increase in patients. We are seeing more doctors writing the patient certification, and we are continuing to educate a number of individuals who come to the dispensary looking for information,” Wildrick said. “The biggest objective right now is to continue to educate the general public on Illinois’ medical cannabis program, cannabis as a medicine and the process one goes about getting enrolled in the program.
“The program is a benefit to patients, Wildrick said.
“It’s just amazing to be able to be a part of helping these patients with these qualifying conditions to have access to a medicine that gives them relief that they’re looking for and gives them a better quality of life than they had previously,” she said. “That counts for a lot.
“Revolution Cannabis Analytics is a division of Revolution Enterprises, which manages state-of-the-art cannabis cultivation and laboratory facilities in Barry and Delavan. It wants to better understand the unique effects of cannabinoids, a class of compounds found in the cannabis plant, and the types of relief they may provide.
“We will use the results from this study to guide the design of our future breeding and formulation programs, allowing us to create new cannabis strains that provide the most medicinal value,” said Dustin Shroyer, Revolution Enterprises chief operations officer. “This study demonstrated that the majority of cannabinoid profiles help patients with pain, and elevated levels of the unique cannabinoid CBD are directly correlated to an overall increase in patient wellbeing. We will utilize this knowledge to select the best cannabinoid profiles for patients.”
This article was previous published on the Herald-Whig by Deborah Gertz Husar: http://www.whig.com/article/20160328/ARTICLE/303289889